tiprankstipranks
Theravance Biopharma (TBPH)
NASDAQ:TBPH
US Market
TBPH
Theravance Biopharma
RESEARCH TOOLSreports
Want to see TBPH full AI Analyst Report?

Theravance Biopharma (TBPH) Financial Statements

353 Followers

Theravance Biopharma Financial Overview

Theravance Biopharma's market cap is currently $870.75M. The company's EPS TTM is $2.09; its P/E ratio is 3.90; Theravance Biopharma is scheduled to report earnings on May 6, 2026, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 107.46M$ 64.38M$ 57.42M$ 51.35M$ 55.31M
Gross Profit$ 101.95M$ 64.38M$ 16.80M$ -12.05M$ -138.35M
Operating Income$ -13.25M$ -46.95M$ -56.03M$ -91.96M$ -257.78M
EBITDA$ -7.73M$ -38.45M$ -51.65M$ -76.08M$ -232.83M
Net Income$ 105.89M$ -56.42M$ -55.19M$ 872.13M$ -199.43M
Balance Sheet
Cash & Short-Term Investments$ 315.36M$ 88.35M$ 102.43M$ 327.48M$ 173.47M
Total Assets$ 485.57M$ 354.16M$ 382.00M$ 607.40M$ 374.82M
Total Debt$ 75.50M$ 49.82M$ 49.16M$ 52.16M$ 669.52M
Net Debt$ -92.31M$ 12.02M$ 9.61M$ -246.01M$ 579.56M
Total Liabilities$ 188.85M$ 178.62M$ 169.00M$ 165.60M$ 713.39M
Stockholders' Equity$ 296.72M$ 175.54M$ 213.00M$ 441.80M$ -338.57M
Cash Flow
Free Cash Flow$ 238.50M$ -11.87M$ -29.48M$ -187.56M$ -211.26M
Operating Cash Flow$ 238.54M$ -11.54M$ -27.00M$ -186.99M$ -207.86M
Investing Cash Flow$ -105.28M$ 12.28M$ -32.70M$ 1.15B$ 124.49M
Financing Cash Flow$ -3.25M$ -2.50M$ -198.93M$ -758.81M$ 91.86M
Currency in USD

Theravance Biopharma Earnings and Revenue History

Income Statement >

Theravance Biopharma Debt to Assets

Balance Sheet >

Theravance Biopharma Cash Flow

Cash Flow >

Theravance Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >